April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...
April 9, 2024 — Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as ...
April 9, 2024 — UC Davis Health cardiology team members are among the first in the country to treat patients with ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...
April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...
April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...
April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...
April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
April 8, 2024 — Taking beta blockers after a heart attack did not significantly reduce the risk of death or a second ...
April 8, 2024 — Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly ...
April 8, 2024 — People who have had a heart attack or who are at risk for a heart attack and who stopped taking aspirin ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
April 7, 2024 — Strategies such as earning points or small amounts of money encouraged people at high risk for heart ...
April 7. 2024 — A single subcutaneous injection of the investigational drug zilebesiran, when added to existing ...
April 7, 2024 — An estimated 1 in 5 U.S. adults—and more than 2 in 5 adults aged 60 years and older—have elevated ...